Drug-Eluting Stent Study Evaluating a New Technology in Patients with Symptomatic Ischemic Heart Disease due to Coronary Artery Blockage.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 17 Jul 2018

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Sirolimus (Primary)
Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Ischaemic heart disorders
Focus First in man; Therapeutic Use
Acronyms DIRECT; DIRECT I FIM; DIRECT-I
Sponsors Svelte Medical Systems

11 Jul 2018 Status changed from active, no longer recruiting to completed.
23 May 2013 Final 6 and 12-month results were presented at the 2013 EuroPCR meeting and have been published in EuroIntervention, according a Svelte Medical Systems media release.
30 Jan 2013 Positive 6-month results have been reported in a Svelte Medical Systems media release. Final 6-month data will be presented at a medical symposia later in 2013.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com